Pneumocystis Jirovecii Pneumonia (pcp) - Infectious Diseases

Relevant Publications

Trimethoprim-sulfamethoxazole combined with echinocandins versus trimethoprim-sulfamethoxazole alone for Pneumocystis pneumonia in patients without human immunodeficiency virus infection: A nationwide retrospective cohort study.

Issue Release: 2024

Commercial loop-mediated isothermal amplification (LAMP) assay for rapid diagnosis of Pneumocystis pneumonia: An alternative to immunofluorescence assays.

Issue Release: 2024

A retrospective study of intravenous pentamidine for PCP prophylaxis in adult patients with hematological malignancies - its utility during respiratory virus pandemics.

Issue Release: 2024

Characteristics and prognosis factors of Pneumocystis jirovecii pneumonia according to underlying disease: a retrospective multicentre study.

Issue Release: 2024

Development of a clinical risk score for the prediction of Pneumocystis jirovecii pneumonia in hospitalised patients.

Issue Release: 2024

Infection image: cystic pneumocystis jirovecii pneumonia - forgotten?

Issue Release: 2024

Outcome of Pneumocystis Jirovecii pneumonia (PcP) in post-CAR-T patients with hematological malignancies.

Issue Release: 2024

Myelotoxicity and kidney dysfunction related to the use of trimethoprim-sulfamethoxazole for the treatment of Pneumocystis jirovecii pneumonia: a case report of severe adverse events with a common drug.

Issue Release: 2024

Computed tomography-based radiomics improves non-invasive diagnosis of Pneumocystis jirovecii pneumonia in non-HIV patients: a retrospective study.

Issue Release: 2024

Denosumab in a pediatric kidney transplant recipient with late, resistant hypercalcemia secondary to Pneumocystis jirovecii pneumonia.

Issue Release: 2024

Clinical characteristics and prognosis of patients with severe pneumonia with Pneumocystis jirovecii colonization: A multicenter, retrospective study.

Issue Release: 2024

Elevated serum lactate dehydrogenase aids prediction of mortality in Pneumocystis jirovecii pneumonia without underlying human immunodeficiency virus infection - Derivation of a clinical risk score.

Issue Release: 2024

Outcomes of low-dose trimethoprim-sulfamethoxazole treatment in patients with non-HIV pneumocystis pneumonia: A nationwide Japanese retrospective cohort study.

Issue Release: 2024

Predictive models-assisted diagnosis of AIDS-associated Pneumocystis jirovecii pneumonia in the emergency room, based on clinical, laboratory, and radiological data.

Issue Release: 2024

Comparative Efficacy and Safety of Pneumocystis jirovecii Pneumonia Prophylaxis Regimens for People with HIV: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.

Issue Release: 2024

Comparison of the outcomes of Pneumocystis jirovecii pneumonia in rheumatoid arthritis patients treated with and without biologics.

Issue Release: 2024

Case Report of COVID-19 and Pneumocystis coinfection in a pediatric patient with a history of receiving high dose steroid therapy.

Issue Release: 2023

The effect of COVID-19 on the frequency of Pneumocystis jirovecii pneumonia: a monocentric, retrospective, and observational study.

Issue Release: 2023

Non-small cell lung cancer with bone metastasis and pneumocystis pneumonia in a pregnant woman: a case report and literature review.

Issue Release: 2023

Clinical significances of mutations in dihydropteroate synthase in Pneumocystis jirovecii pneumonia among non-HIV-infected patients.

Issue Release: 2023

What Research is Being Done to Combat These Diseases?

What is the Global Impact of Hepatitis B?

How Do Aedes Mosquitoes Transmit Diseases?

How Can Aedes Aegypti Be Controlled?

Why are travel precautions important?

Why are Genomic Studies Important in Infectious Diseases?

What Are the Primary Methods of Mosquito Control?

How is Co-Infection Diagnosed?

What Challenges Does the RBM Partnership Face?

What are the Symptoms of Ebola?

Pneumocystis Jirovecii Pneumonia (pcp) - Infectious Diseases

Relevant Publications

Partnered Content Networks

Relevant Topics